KC Nwakalor—The New York Times/Redux

In 2017, when Dr. Dimie Ogoina sounded the alarm on a new presentation of Mpox (formerly known as monkeypox) that he was seeing in his home country of Nigeria, the world wasn’t ready to listen. Recognizing the importance and potential implications for global spread, he persisted, documenting the potential for sexual transmission of Mpox and publishing the data in high-impact scientific journals. As the global Mpox outbreak unfolded in 2022, Dimie’s insights became critically important to developing better strategies to prevent and control outbreaks.

Dimie is also a passionate champion for global health equity. He has often made the point that Mpox is not a new disease and that had the world paid attention sooner, we could have avoided a global outbreak. It is this drive that has led Dimie to make significant contributions to the field through his advocacy, leadership, and research.

Rimoin is a professor of epidemiology at UCLA and has been studying Mpox and other emerging diseases in Central Africa for two decades

More Must-Reads From TIME

Contact us at letters@time.com.

Olena Zelenska
Lionel Messi
Aubrey Plaza
Michael B. Jordan
Colleen Hoover
5 stories